

When joint pain and inflammation don’t settle with standard medication, biologics infusion therapy offers a targeted way to control the disease at its source. At Nishchay Hospital, infusions are planned, prescribed and supervised by Dr. Niti Y. Kedia, EULAR-trained Rheumatologist, in a monitored clinical setting.
When joint pain and inflammation don’t settle with standard medication, biologics infusion therapy offers a targeted way to control the disease at its source. At Nishchay Hospital, infusions are planned, prescribed and supervised by Dr. Niti Y. Kedia, EULAR-trained Rheumatologist, in a monitored clinical setting.
Biologics are a class of advanced medicines that work by targeting specific parts of the immune system responsible for driving inflammation, instead of suppressing the immune system broadly. In infusion therapy, these medicines are delivered directly into the bloodstream through an IV line, allowing them to act more precisely and, in many cases, more effectively than tablets alone.
For patients with rheumatoid arthritis, lupus and other autoimmune conditions who don’t respond adequately to conventional DMARDs, biologics infusion therapy can help bring disease activity under control, protect joints from further damage, and improve day-to-day function.
At Nishchay Hospital, biologics infusion is considered for patients with moderate-to-severe autoimmune and inflammatory conditions, including:
For patients whose joint inflammation continues despite DMARDs, biologics help slow disease progression and reduce joint damage.
Targeted infusion therapy can help control immune overactivity and manage flares affecting joints, skin and other organs.
Infusions can ease joint inflammation and stiffness associated with psoriatic arthritis, alongside skin symptom management.
Biologics can reduce spinal and joint inflammation, helping to improve mobility and reduce stiffness.
Infusion therapy helps control blood vessel inflammation, manage disease activity, and reduce the risk of autoimmune damage to vital organs.
Depending on disease activity and response to prior treatment, other rheumatological conditions may also benefit from biologics infusion.
Biologics infusion isn’t the first step for every patient – it’s usually considered when:
If any of this sound familiar, it’s worth getting evaluated early rather than waiting for things to worsen.
Biologics are advanced medicines designed to target specific parts of the immune system responsible for inflammation. They may be recommended when conventional treatments do not provide adequate disease control or when the condition is severe or difficult to manage.
At Nishchay Hospital, biologics infusion therapy is provided under specialist supervision, with appropriate monitoring before, during, and after treatment. The choice of biologic, dosage, and infusion schedule depends on the patient’s condition, disease activity, previous treatments, and overall health.
Every infusion at Nishchay Hospital follows a structured, closely supervised process:
Dr. Niti Y. Kedia is a gold-medalist physician trained in Internal Medicine, with focused post-doctoral training in Rheumatology. She provides specialised arthritis and autoimmune care in Akola, backed by advanced diagnostic skills and international training.
She completed a 2-year post-doctoral Fellowship in Rheumatology at the Indian Spinal Injuries Centre, Delhi, and holds EULAR training in musculoskeletal ultrasound – a precision imaging technique that allows early and accurate detection of joint inflammation, often before it is visible on standard X-rays.
Dr. Niti Y. Kedia is a gold-medalist physician trained in Internal Medicine, with focused post-doctoral training in Rheumatology. She provides specialised arthritis and autoimmune care in Akola, backed by advanced diagnostic skills and international training.
She completed a 2-year post-doctoral Fellowship in Rheumatology at the Indian Spinal Injuries Centre, Delhi, and holds EULAR training in musculoskeletal ultrasound – a precision imaging technique that allows early and accurate detection of joint inflammation, often before it is visible on standard X-rays.



It’s used to treat autoimmune and inflammatory rheumatological conditions such as rheumatoid arthritis, lupus, psoriatic arthritis, ankylosing spondylitis and vasculitis, particularly when the disease doesn’t respond well to conventional medication.
Biologics target specific parts of the immune system driving inflammation, and are given directly into the bloodstream via IV, which can make them more effective for patients who haven’t responded to standard oral DMARDs.
Duration varies by medicine and dose, and your rheumatologist will explain the expected time for your specific treatment plan during your consultation.
Biologics are prescribed only after screening confirms suitability, and every infusion is given under clinical supervision with monitoring for reactions, making the process as safe as possible for each patient.
This depends on the specific biologic prescribed and how your condition responds — some medicines are given every few weeks, others at longer intervals, as determined by your rheumatologist.
Yes. Screening blood tests are done before starting therapy to check for infections and confirm that biologics infusion is appropriate for you.
Yes, in many cases biologics are combined with other DMARDs such as methotrexate for better disease control, depending on the individual’s condition.